Ken Griffin’s Akcea Therapeutics Inc AKCA Stock Holding History

Ken Griffin’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25,890	Closed	-$470K	–	11892
2020 Q3	$470K	Sell	25,890 -126,311	-83%	-$1.79M	﹤0.01%	7406
2020 Q2	$2.08M	Buy	152,201 +49,509	+48%	+$764K	﹤0.01%	4495
2020 Q1	$1.47M	Sell	102,692 -186,972	-65%	-$3.07M	﹤0.01%	4661
2019 Q4	$4.91M	Buy	289,664 +262,312	+959%	+$4.88M	﹤0.01%	3105
2019 Q3	$421K	Sell	27,352 -601,342	-96%	-$12.8M	﹤0.01%	7046
2019 Q2	$14.7M	Sell	628,694 -495	-0.1%	-$12.2K	0.01%	1721
2019 Q1	$17.8M	Buy	629,189 +423,922	+207%	+$12.3M	0.01%	1442
2018 Q4	$6.19M	Buy	205,267 +116,623	+132%	+$3.27M	﹤0.01%	2496
2018 Q3	$3.1M	Buy	88,644 +79,661	+887%	+$2.41M	﹤0.01%	3682
2018 Q2	$213K	Buy	+8,983	New	+$214K	﹤0.01%	7793

Ken Griffin's AKCA Position: Q4 2020 in Review

Ken Griffin sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 25,890 shares — an estimated $470K sold.

Ken Griffin first reported a position in AKCA in Q2 2018 and held it in 10 quarters. The position peaked at $17.8M in Q1 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Ken Griffin reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Ken Griffin sold 25,890 Akcea Therapeutics Inc shares in Q4 2020, an estimated $470K.
Ken Griffin first reported a position in Akcea Therapeutics Inc in Q2 2018 and held it in 10 quarters.
Ken Griffin's Akcea Therapeutics Inc position peaked at $17.8M in Q1 2019.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.